ArticleAnnals of translational medicine2022

The anti-Trop-2 antibody-drug conjugate Sacituzumab Govitecan-effectiveness, pitfalls and promises.

Emanuela Guerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.